Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours
about
mRNA vaccines - a new era in vaccinology.Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses.Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines.Resident memory T cells, critical components in tumor immunologyNew Vaccine Technologies to Combat Outbreak Situations
P2860
Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Intralymphatic mRNA vaccine in ...... h of mucosally located tumours
@ast
Intralymphatic mRNA vaccine in ...... h of mucosally located tumours
@en
type
label
Intralymphatic mRNA vaccine in ...... h of mucosally located tumours
@ast
Intralymphatic mRNA vaccine in ...... h of mucosally located tumours
@en
prefLabel
Intralymphatic mRNA vaccine in ...... h of mucosally located tumours
@ast
Intralymphatic mRNA vaccine in ...... h of mucosally located tumours
@en
P2093
P2860
P356
P1433
P1476
Intralymphatic mRNA vaccine in ...... h of mucosally located tumours
@en
P2093
Alexia van Weijnen
Carlo Heirman
Dries Renmans
Joeri L Aerts
Kevin Van der Jeught
Kris Thielemans
Lidia Daszkiewicz
Lukasz Bialkowski
P2860
P2888
P356
10.1038/SREP22509
P407
P577
2016-03-02T00:00:00Z
P5875
P6179
1005634868